Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunological Tests Detects Schistosomiasis in Low-Endemicity Area

By LabMedica International staff writers
Posted on 02 Apr 2014
The prevalence of Schistosoma mansoni infection has been systematically determined using the indirect immunofluorescence assay-immunoglobulin M (IFA-IgM) and circumoval precipitin test (COPT) techniques with serum samples.

Schistosomiasis is a major public health problem, with an estimated 200 million people infected worldwide and as a consequence of effective schistosomiasis control programs based on mass or selective chemotherapy, basic sanitation measures, and use of molluscicides, the prevalence of human schistosomiasis has decreased considerably.

Parasitologists from the University of São Paulo (Brazil) conducted a cross-sectional study was from April to December 2011 in several districts on the outskirts of Barra Mansa, Rio de Janeiro, Brazil and collected 572 randomized feces and serum samples. More...
The majority of subjects in the study population were females. The average age of the population was 40 to 41 years old.

Fecal samples were processed and evaluated using the qualitative-quantitative Helm Test Kit (KK-HH, Biomanguinhos Fiocruz; Rio de Janeiro, Brazil). The COPT was used to detect antibody reactions against excretion and secretion products of S. mansoni eggs using previously described techniques. The IFA-IgM reading was performed using an Olympus BX-FLA fluorescence microscope (Olympus Corporation, Tokyo, Japan) equipped with an epi-illumination system.

The IFA-IgM identified the greatest number of S. mansoni infections (91/572, 15.9%), followed by COPT (29/572, 5.1%). The Helm test kit parasitological techniques identified the fewest infections (5/572, 0.9%). The COPT positivity showed a statistically significant difference compared with parasitological techniques. The level of agreement between COPT and parasitological techniques was higher than that with IFA-IgM. The higher COPT positivity compared with parasitological techniques may be caused by oviposition occurrence, where eggs deposited in the deepest layers of the intestine can be detected even in the absence of eggs in feces, especially in chronic infections in patients over 40 years of age and with low parasite load.

The authors concluded that positivity rates were highest using IFA-IgM compared with parasitological techniques and COPT. Therefore, it could be used as a primary approach to screen a large number of suspected cases of schistosomal infection in epidemiological studies, in combination with the KK-HH techniques and confirmation of IFA-IgM-positive cases with COPT techniques would be beneficial in low-endemicity areas. The study was published on March 17, 2014, in the American Journal of Tropical Medicine and Hygiene.

Related Links:
University of São Paulo
Biomanguinhos
Olympus Corporation



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.